May 30
Pfizer Shares Fall After-Hours After Suspension Of Cancer Study #ASCO20 https://t.co/kkMwIf4371

May 30
Genentech: FDA Approves Tecentriq in Combination With Avastin for Some Liver Cancer Patients #ASCO20 https://t.co/PZv8m8CUvk

May 30
Katie Kelley, MD, of @UCSF discusses fitting tremelimumab + durvalumab into HCC treatment algorithms #ASCO20 https://t.co/PgkmKoeVoz

May 30
Nicholas Vogelzang, MD, FAC, FASCO, of @CCCNevada explains how cabazitaxel should be used in various lines of treat… https://t.co/WAkWkUFmEf

May 30
Vivek Subbiah @VivekSubbiah , MD, of @MDAndersonNews on the FDA approved product, selpercatanib, for RET-driven lu… https://t.co/ILwAZtxXfh

May 30
Final Prosper Results Show Xtandi® (Enzalutamide) Significantly Extends Overall Survival In Men With Non-Metastatic… https://t.co/BobQ15CZOj

May 30
SPEAR T-cells Targeting MAGE-A4 Demonstrate New Responses in Esophagogastric Junction (EGJ), Lung, and Head and Nec… https://t.co/UKu93KJpLA

May 30
Vivek Subbiah @VivekSubbiah , MD, @MDAndersonNews describes solid tumor tests for RET fusion and similarities it m… https://t.co/9MlHzs422k

May 30
Saad Usmani @szusmani, MD, of @LevineCancer outlines the Phase 1 study investigating teclistamab in relapsed/refrac… https://t.co/ODs1HrnftW

May 30
Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early… https://t.co/LM1kg7cgcx